ARWR
NASDAQStockArrowhead Pharmaceuticals, Inc.
$55.44-2.72 (-4.68%)
52-Week Range
$9.99
$73.00
Key Stats
Market Cap
7.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.30
Volume
2.5M
Avg Volume
2.4M
Performance
1M
-10.63%
3M
-19.63%
6M
+91.87%
YTD
-18.85%
1Y
+265.03%
3Y
+107.12%
5Y
-23.44%
Price Chart
ETF Exposure
ARWR is held by 133 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GNOM | Global X - Genomics & Biotechnology ETF | 5.79% |
| MSGR | Direxion mRNA ETF | 3.68% |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 3.67% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 3.54% |
| PBE | Invesco Biotechnology & Genome ETF | 2.66% |
| RFG | Invesco S&P MidCap 400 Pure Growth ETF | 2.00% |
| WDNA | WisdomTree BioRevolution Fund | 1.30% |
| BBP | Virtus Biotech ETF | 1.29% |
| ETHO | Amplify Etho Climate Leadership U.S. ETF | 1.24% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 1.22% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 1.21% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 1.07% |
| XBI | State Street SPDR S&P Biotech ETF | 1.05% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 1.00% |
| IBB | iShares Biotechnology ETF | 0.65% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 0.63% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.63% |
| IWO | iShares Russell 2000 Growth ETF | 0.62% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.61% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.61% |
| FDMO | FIDELITY MOMENTUM FACTOR ETF | 0.58% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.58% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.56% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 0.53% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.51% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.50% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 0.47% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 0.47% |
| VFLQ | Vanguard U.S. Liquidity Factor ETF | 0.46% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.42% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.41% |
| STXK | Strive Small-Cap ETF | 0.39% |
| PSC | Principal U.S. Small-Cap Multi-Factor ETF | 0.39% |
| DMRM | DeltaShares S&P 400 Managed Risk ETF | 0.35% |
| VTWO | Vanguard Russell 2000 ETF | 0.30% |
| VBK | Vanguard Small-Cap Growth ETF | 0.28% |
| RSSL | Global X - Russell 2000 ETF | 0.27% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.27% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.27% |
| IWM | iShares Russell 2000 ETF | 0.27% |
| STSB | iShares Factors US Small Blend Style ETF | 0.26% |
| IJH | iShares Core S&P Mid-Cap ETF | 0.25% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.25% |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | 0.24% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.24% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.24% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.24% |
| PWS | Pacer WealthShield ETF | 0.23% |
| JMEE | JPMorgan Small & Mid Cap Enhanced Equity ETF | 0.22% |
| SMOX | Horizon Small/Mid Cap Core Equity ETF | 0.22% |
Page 1 of 3Next
About ARWR ETF Exposure
Arrowhead Pharmaceuticals, Inc. (ARWR) is held by 133 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.8B, ARWR is a widely held institutional stock. The stock currently trades at $55.44. Investors can gain exposure to ARWR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ARWR, sorted by portfolio weight.